These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 3724787

  • 21. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients.
    Limburg PC, The TH, Hummel-Tappel E, Oosterhuis HJ.
    J Neurol Sci; 1983 Mar; 58(3):357-70. PubMed ID: 6842264
    [Abstract] [Full Text] [Related]

  • 22. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ, Lo YL.
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Anti-skeletal muscle antibodies in the sera from myasthenic patients with thymoma: identification of anti-myosin, actomyosin, actin, and alpha-actinin antibodies by a solid-phase radioimmunoassay and a western blotting analysis.
    Ohta M, Ohta K, Itoh N, Kurobe M, Hayashi K, Nishitani H.
    Clin Chim Acta; 1990 Mar 15; 187(3):255-64. PubMed ID: 2323065
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A, Newsom-Davis J.
    Clin Exp Immunol; 1982 Aug 15; 49(2):266-72. PubMed ID: 7127905
    [Abstract] [Full Text] [Related]

  • 31. Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis.
    Heilbronn E, Lefvert AK, Stålberg E.
    Muscle Nerve; 1978 Aug 15; 1(5):427-31. PubMed ID: 263985
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cross-reactivity of anti-acetylcholine receptor autoantibodies.
    Garlepp MJ, Kay PH, Dawkins RL, Bucknall RC, Kemp A.
    Muscle Nerve; 1981 Aug 15; 4(4):282-8. PubMed ID: 7254231
    [Abstract] [Full Text] [Related]

  • 34. Antibody-induced degradation of acetylcholine receptor in myasthenia gravis: clinical correlates and pathogenetic significance.
    Tronconi BC, Brigonzi A, Fumagalli G, Sher M, Cosi V, Piccolo G, Clementi F.
    Neurology; 1981 Nov 15; 31(11):1440-4. PubMed ID: 7198191
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Molecular aspects of experimental autoimmune myasthenia gravis.
    Fuchs S, Bartfeld D, Mochly-Rosen D, Schmidt-Hopfeld I, Tarrab-Hazdai R.
    Prog Clin Biol Res; 1981 Nov 15; 63():405-17. PubMed ID: 7031685
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.